Distinct microglia alternative splicing in Alzheimer's disease

Yanjun Lu1, Lu Tan2, Jiazhao Xie3

  • 1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Aging
|August 25, 2022
PubMed

Insights

This study reveals cell-specific alternative splicing events in microglia from Alzheimer's disease (AD) mouse models. These findings highlight novel molecular mechanisms contributing to AD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alternative splicing (AS) is implicated in Alzheimer's disease (AD), but cell type-specific analyses are limited.
  • Microglia play crucial roles in AD pathogenesis, yet their AS landscape in this disease remains underexplored.

Purpose of the Study:

  • To characterize cell type-specific alternative splicing events in hippocampal microglia from an Alzheimer's disease mouse model.
  • To identify novel molecular pathways and potential therapeutic targets in AD pathogenesis.

Main Methods:

  • Hippocampal microglia were isolated from APP (Alzheimer's disease model) and non-transgenic mice.
  • RNA sequencing data (GSE171195) were analyzed for various AS events (SE, A3SS, RI, A5SS, MXE) using rMATS and maser.
  • Differential gene expression, gene ontology, and correlation analyses were performed.

Main Results:

  • 95 significant AS events were identified in microglia, with skipped exons (SE) being the most prevalent type.
  • Autophagy genes were predominantly affected by SE, actin depolymerization genes by alternative 3' splice sites (A3SS), and synaptic plasticity genes by retained introns (RI).
  • These AS events may be driven by altered splicing factor activity in AD.

Conclusions:

  • This study provides the first comprehensive analysis of microglia-specific alternative splicing in Alzheimer's disease.
  • The identified AS events offer new insights into the molecular mechanisms underlying AD pathogenesis.
  • These findings may pave the way for novel therapeutic strategies targeting microglia in AD.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.7K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
650